EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity
about
Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRAInsights into pancreatic cancer etiology from pathway analysis of genome-wide association study data.Genetic variation and clinical heterogeneity in cystic fibrosisThe influence of genetics on cystic fibrosis phenotypes.Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.Genetic influences on cystic fibrosis lung disease severity.DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.Modifier genes in Mendelian disorders: the example of cystic fibrosisDisease-modifying genes and monogenic disorders: experience in cystic fibrosis.Genetic modifiers and oligogenic inheritance.Inflammation and its genesis in cystic fibrosis.Disrupted post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by a 5'UTR mutation is associated with a CFTR-related disease.Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.Effect of SNP polymorphisms of EDN1, EDNRA, and EDNRB gene on ischemic stroke.
P2860
Q28547212-E0C25244-73A4-4D9E-9F3C-79C0FE4692BAQ28943344-3E2ACFD0-5E1E-4C0A-BF8A-A0B42D350684Q30573020-096415F0-D4B1-453B-9A97-A92043F331B2Q33645546-7D72B922-2635-42A3-9C76-2D5FCA753278Q36526522-20EDAFCC-CA12-427C-8353-B757605DF9D6Q36686765-76D20E7F-AA6F-4F7B-BA55-98F1C11B99FDQ36785547-2DD25A94-5F49-4EDB-8AFD-5899EA41FE91Q37642982-058777DA-4B51-45C7-9ABA-0EF61E454F69Q37822861-58B74BC0-3601-493E-B98E-1A4AF902AC6EQ38233032-59612DB6-B5AF-4E13-9C1A-00848D2468D3Q38511788-DA486B57-EA1B-44B0-AC65-2A8833ED503FQ38579962-F3587D8F-4FAB-4AEA-B890-579F2BF6E755Q39491182-E1879E01-F4F5-4F61-B9D5-EF11DABDCB6FQ44788767-72F3FFF9-69CF-4D2A-A9C8-E4242263970EQ51153564-AB27C738-327F-422C-B242-151EF79D5AA9
P2860
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
EDNRA variants associate with ...... sis pulmonary disease severity
@ast
EDNRA variants associate with ...... sis pulmonary disease severity
@en
EDNRA variants associate with ...... sis pulmonary disease severity
@nl
type
label
EDNRA variants associate with ...... sis pulmonary disease severity
@ast
EDNRA variants associate with ...... sis pulmonary disease severity
@en
EDNRA variants associate with ...... sis pulmonary disease severity
@nl
prefLabel
EDNRA variants associate with ...... sis pulmonary disease severity
@ast
EDNRA variants associate with ...... sis pulmonary disease severity
@en
EDNRA variants associate with ...... sis pulmonary disease severity
@nl
P2093
P2860
P1476
EDNRA variants associate with ...... sis pulmonary disease severity
@en
P2093
Alan Genatossio
Charles G Gallagher
Christine Rodgers
Clare O'Connor
Dawn Wiese
Douglas Londono
Edward McKone
Katrina A B Goddard
Madeleine Ennis
P2860
P356
10.1152/PHYSIOLGENOMICS.00185.2009
P407
P577
2010-03-03T00:00:00Z